Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT05480644
Status
Recruiting
Apply to this trial

Conditions

  • Brain Metastases, Adult
  • Brain Tumor, Primary

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.

Key Dates

Start date
Dec 1, 2022
Status verified
Nov 2025
Primary completion
Dec 31, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Number of circulating immune cells in peripheral blood [ Time Frame: 6 weeks post radiation therapy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke Cancer CenterDurhamNorth Carolina27710
Kaitlin Bailey, RN
[email protected]
919-668-3726
Linda Kaltenbach, PhD
[email protected]
Eugene Vaios, MD MBA (PRINCIPAL_INVESTIGATOR)
Zach Reitman, MD PhD (PRINCIPAL_INVESTIGATOR)
Scott Flody, MD PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Durham, NC

By research site
Duke Cancer Center· Durham, NC

Related Studies